Acta Paediatrica · 2007 · 59 citations · 5 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicineNeonatal HealthNeonatologyPregnancyPrenatal AssessmentPrenatal CarePrenatal DevelopmentPrenatal Risk AssessmentPrenatal ToxicologyCannabinoid Exposure AssessmentMass Spectrometric DetectionMass Spectrometric QuantificationPrenatal Cannabis ExposurePrenatal Drug ExposurePrenatal Substance ExposureSubstance Exposure At Birth
AIM: To investigate the prevalence of in utero exposure to cannabis in a cohort of 974 mother-infants dyads from Barcelona (Spain). METHODS: A validated gas chromatographic-mass spectrometric assay was used for meconium analysis. RESULTS: Prenatal exposure to cannabis was detected in 5.3% newborns; however, only 1.7% of the participating mothers disclosed gestational drug use. Ethnicity was not associated with cannabis use, nor were the maternal features or newborns somatometry. A significantly higher percentage of cannabis using mothers had a managerial professional job versus nonusers. CONCLUSIONS: Meconium analysis is especially important to identify neonates who have been exposed to cannabis in utero, which appear normal at birth and therefore may not be recognized. Timely detection of these newborns at risk provides the basis for appropriate treatment and adequate medical and social follow-up.
5
Drug Screening of Newborns by Meconium Analysis: A Large-Scale, Prospective, Epidemiologic Study
Enrique M. Ostrea, Mark Brady, Sybil Gause et al. · PEDIATRICS · 1992 · 346 citations
The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report
Barry M. Lester, Mahmoud A. ElSohly, Linda L. Wright et al. · PEDIATRICS · 2001 · 307 citations
Emilia Marchei, Manuela Pellegrini, Roberta Pacifici et al. · Therapeutic Drug Monitoring · 2006 · 40 citations
Pharmacy, Pharmacology, Toxicology +17